Northwire Canada EditionSaturday, August 1, 2026
Sign inSubscribe
Northwire
⌕
S 0.140 +0.0% BNKR 4.40 −2.2% QRO 0.045 +0.0% VCT 0.075 +36.4% PPP 1.15 +0.9% LMG 0.390 +0.0% GRDM 0.140 +0.0% ABRA 13.58 −4.1% WHY 0.295 +1.7% HHH 3.94 −0.2% COS 0.060 +0.0% NOB 0.065 −23.5% MEK 0.055 +0.0% TGOL 0.105 −4.5% FCI 0.400 −7.0% SGQ 0.350 +0.0% S 0.140 +0.0% BNKR 4.40 −2.2% QRO 0.045 +0.0% VCT 0.075 +36.4% PPP 1.15 +0.9% LMG 0.390 +0.0% GRDM 0.140 +0.0% ABRA 13.58 −4.1% WHY 0.295 +1.7% HHH 3.94 −0.2% COS 0.060 +0.0% NOB 0.065 −23.5% MEK 0.055 +0.0% TGOL 0.105 −4.5% FCI 0.400 −7.0% SGQ 0.350 +0.0%
M&A / Property

Global Digital Health Market Size Projected to Reach $1.5 Trillion By 2032 as A.I. Technology Enhances Operations

By The Northwire Desk — AI Analysis Nov 11, 2025 · 08:30 AID · 0.185 Auxellence Health Corporation
AID · Price

Executive Summary

  • HEALWELL AI completed strategic transactions with WELL Health Technologies and its subsidiaries, monetizing non‑core assets and adding approximately $9.4 million of cash to its balance sheet.
  • Aleen Inc. announced the start of an early concept‑testing phase for a “Smart Wellness Analytics” feature aimed at delivering AI‑supported wellness insights (non‑clinical).
  • Teladoc Health granted a new CTO a combined award of 86,906 RSUs and up to 173,812 PSUs, reflecting ongoing executive compensation activity.

Key Details

  • HEALWELL AI – Strategic Transactions
  • Sale of Polyclinic Family Medicine and Specialty Clinics Group to WELL Clinics.
  • Sale of HEALWELL’s interest in Mutuo Health Solutions to WELLSTAR.
  • Creation of a joint‑venture clinical research partnership with WELL Health Technologies.
  • Transactions closed Nov 1, 2025 after satisfying customary conditions (third‑party consents, regulatory and exchange approvals).

  • Generated ≈ $9.4 million cash proceeds, strengthening HEALWELL’s balance sheet.

  • Aleen Inc. – Early Concept Testing for Smart Wellness Analytics

  • Initiated a testing phase to explore user interaction models, technical feasibility, and scenario‑based evaluations for future analytics.
  • Focus on “responsible AI‑supported insight tools” that remain outside diagnostic or medical functions.

  • Activities include assessing real user needs, exploring analytical approaches to trend recognition, and evaluating structured insights for personal well‑being awareness.

  • Teladoc Health – CTO Inducement Award

  • Effective Nov 1, 2025, Dave Ross (incoming Chief Technology Officer) received:
    • 86,906 Restricted Stock Units (RSUs) of Teladoc common stock (par $0.001).
    • Performance Stock Units (PSUs) targeting 86,906 shares (up to 173,812 shares earnable).
  • RSU vesting: one‑third after the first anniversary, remainder quarterly over two years.

  • PSU vesting tied to achievement of financial performance metrics over three years.

  • Evolent Health & American Oncology Network – New Cancer‑Care Model

  • Partnership introduces a “gold‑card” system that removes prior‑authorization requirements for providers meeting quality benchmarks.
  • Combines Evolent’s care navigation program with AON’s oncology network to improve clinical decision‑making and patient connectivity.

  • Rollout planned in select markets during the upcoming year.

  • Industry Context (Market Commentary)

  • Global digital health market projected to grow from $427.24 bn (2025) to $1,500.69 bn by 2032 (CAGR ≈ 19.7%).
  • AI and machine‑learning applications cited as key growth drivers across imaging, patient monitoring, and device automation.

Notable Quotes

  • “These transactions accelerate our evolution into becoming a pure‑play, high‑margin AI and SaaS software and services business…” – James Lee, CEO, HEALWELL AI.
  • “Our current focus is on understanding how an analytical tool can responsibly support everyday well‑being…,” – Anastasiia Kalashnik, PR Specialist, Aleen Inc.
Read the original news release →